AngioDynamics (ANGO) to Release Quarterly Earnings on Tuesday

AngioDynamics (NASDAQ:ANGO - Get Free Report) will likely be announcing its Q4 2025 earnings results before the market opens on Tuesday, July 15th. Analysts expect the company to announce earnings of ($0.13) per share and revenue of $74.26 million for the quarter.

AngioDynamics Price Performance

NASDAQ ANGO opened at $9.19 on Tuesday. The stock's fifty day moving average price is $9.87 and its 200 day moving average price is $10.07. AngioDynamics has a 1 year low of $5.47 and a 1 year high of $13.50. The company has a market cap of $373.18 million, a price-to-earnings ratio of -9.10 and a beta of 0.60.

Institutional Investors Weigh In On AngioDynamics

An institutional investor recently raised its position in AngioDynamics stock. Goldman Sachs Group Inc. lifted its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 9.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 259,226 shares of the medical instruments supplier's stock after acquiring an additional 22,658 shares during the quarter. Goldman Sachs Group Inc. owned 0.64% of AngioDynamics worth $2,434,000 as of its most recent SEC filing. Institutional investors and hedge funds own 89.43% of the company's stock.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a "buy" rating and issued a $16.00 target price (up from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.